Medical Xpress on MSN13d
New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
8d
News Medical on MSNNew deep learning method could revolutionize heart health monitoringCoronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon emission ...
Proteins' amino-acid sequences appear to guide their access to blob-like aggregates involved in many cell processes ...
R1 designation is the highest classification that universities can attain for research activity. SLU’s rise to R1 is the result of a decade-long, institution-wide effort to become a national exemplar ...
There will also be a free Super Bowl party with Bucs players on hand, and the Florida Orchestra playing with a percussion ...
8don MSN
WASHINGTON — President Donald Trump plans to on Monday formally announce 25% tariffs on steel and aluminum imports as part of an aggressive effort to remake the existing terms of world trade that so ...
After an extensive international search, the Donald Danforth Plant Science Center has named Giles Oldroyd, PhD, as its next President. Oldroyd, a renowned ...
LVMH is making long-term deals—and they’re not done. The post LVMH’s New Push: World’s Most Powerful Luxury Group Is Coming ...
Internationally recognized plant scientist named next President of the Danforth Plant Science Center
After an extensive international search, the Donald Danforth Plant Science Center has named Giles Oldroyd, PhD, as its next ...
4d
AZoSensors on MSNScientists Develop High-Sensitivity Sensors for Detecting Toxic ChemicalsA $1 million DTRA grant enables researchers to create efficient detection methods for sulfur mustard, crucial for minimizing exposure in hazardous environments.
Viehbacher, “Biogen”) announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as treatment for early AD (mild cognitive impairment due to ...
Josh was finishing up his finance degree at the University of Ontario Institute of Technology ... been published in the Columbia Missourian, St. Louis Post-Dispatch, Kansas City Star, Politico ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results